Mortality predictors in hospitalised COVID-19 patients and the role of anti-SARS-CoV-2 IgG antibodies and remdesivir.

Sergio Venturini,Daniele Orso,Francesco Cugini, Danilo Villalta,Maurizio Tonizzo,Alessandro Grembiale, Ada Zanier, Serena Cecco,Astrid Callegari, Silvia Duranti, Giovanni Del Fabro,Massimo Crapis

Le infezioni in medicina（2023）

引用 0|浏览0

暂无评分

摘要

S-antibodies and remdesivir could play a protecting role in increasing the survival of hospitalized COVID-19 patients who are not suffering from a critical disease. Advanced age is a risk factor for poor outcomes among infected people.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要